Press Releases

Want to interview a scientist about a recent breakthrough at the Gladstone Institutes? Please contact Gladstone’s press-relations staff at 415 734 5000. We’ll be delighted to connect you to one or more of our researchers.

2013

Gladstone Scientists Discover that DNA Damage Occurs as Part of Normal Brain Activity

SAN FRANCISCO, CA—March 24, 2013—Scientists at the Gladstone Institutes have discovered that a certain type of DNA damage long thought to be particularly detrimental to brain cells can actually be...

Gladstone Scientist Named Inaugural Winner of Breakthrough Prize in Life Sciences

SAN FRANCISCO, CA—February 20, 2013—Gladstone Institutes’ Senior Investigator Shinya Yamanaka, MD, PhD, is one of 11 medical researchers to win a new, high-profile $3 million award from a group of...

Unique Protein Interaction May Drive Most Common Genetic Cause of Parkinson’s Disease

San Francisco, CA—January 7, 2013—The most devastating aspect of Parkinson’s disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement. It may...

2012

Gladstone Scientists Identify Powerful Infection Strategy of Widespread and Potentially Lethal Virus

SAN FRANCISCO, CA—December 20, 2012—Scientists at the Gladstone Institutes have mapped the molecular mechanism by which a virus known as cytomegalovirus (CMV) so successfully infects its hosts. This...

Gladstone Scientists Discover Novel Mechanism by Which Calorie Restriction Influences Longevity

SAN FRANCISCO, CA—December 6, 2012—Scientists at the Gladstone Institutes have identified a novel mechanism by which a type of low-carb, low-calorie diet—called a “ketogenic diet”—could delay the...

Gladstone Scientists: “ApoE Is an Ideal Target for Halting Progression of Alzheimer’s Disease”

SAN FRANCISCO, CA—December 5, 2012—Scientists at the Gladstone Institutes are recommending a shift in efforts to treat Alzheimer’s disease by developing drugs that target the apoE4 protein, which has...

ALS Therapy Development Institute and Gladstone Institutes Collaborate to Discover Potential ALS Treatments

CAMBRIDGE, MA and SAN FRANCISCO, CA—December 4, 2012— The ALS Therapy Development Institute (ALS TDI) and the Gladstone Institutes today announced the formation of a research collaboration to speed...

Gladstone Scientists Identify Key Biological Mechanism in Multiple Sclerosis

SAN FRANCISCO, CA—November 27, 2012—Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)—a disease that causes...

Gladstone President to Receive Prestigious Pacesetter Award

SAN FRANCISCO, CA—October 29, 2012—Gladstone President R. Sanders "Sandy" Williams, MD, will receive the ARCS Foundation’s 2012 Pacesetter Award next week for his lifelong dedication to furthering...

Gladstone, Stanford Scientists Collaborate to Block Toxic Protein that Plays Key Role in Lou Gehrig’s Disease

SAN FRANCISCO, CA—October 28, 2012— Scientists at the Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein...